Literature DB >> 27388452

Early Intervention in Lung Cancers With Rapid Plasma Genotyping for EGFR and KRAS Mutations-Reply.

Adrian G Sacher1, Ryan S Alden2, Geoffrey R Oxnard3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27388452     DOI： 10.1001/jamaoncol.2016.1963

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

Review 1.  Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2017-11-10       Impact factor: 6.639

2.  Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

Authors:  Paul van der Leest; Birgitta Hiddinga; Anneke Miedema; Maria L Aguirre Azpurua; Naomi Rifaela; Arja Ter Elst; Wim Timens; Harry J M Groen; Léon C van Kempen; T Jeroen N Hiltermann; Ed Schuuring
Journal:  Mol Oncol       Date:  2021-09-25       Impact factor: 6.603

3.  Evaluation of pre-analytical conditions and comparison of the performance of several digital PCR assays for the detection of major EGFR mutations in circulating DNA from non-small cell lung cancers: the CIRCAN_0 study.

Authors:  Jessica Garcia; Eric Dusserre; Valérie Cheynet; Pierre Paul Bringuier; Karen Brengle-Pesce; Anne-Sophie Wozny; Claire Rodriguez-Lafrasse; Gilles Freyer; Marie Brevet; Léa Payen; Sébastien Couraud
Journal:  Oncotarget       Date:  2017-09-21

Review 4.  Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!

Authors:  Lucile Durin; Anne Pradines; Céline Basset; Bryan Ulrich; Laura Keller; Vincent Dongay; Gilles Favre; Julien Mazieres; Nicolas Guibert
Journal:  Cells       Date:  2020-11-16       Impact factor: 6.600

Review 5.  Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer.

Authors:  Jhanelle Gray; Jeffrey C Thompson; Erica L Carpenter; Ehab Elkhouly; Charu Aggarwal
Journal:  Oncologist       Date:  2021-07-26       Impact factor: 5.837
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.